Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 29.60
+1.30 (4.59%)
May 21, 2026, 11:58 AM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 38.88 million as of May 21, 2026. Its market cap has increased by 131.97% in one year.
Market Cap
38.88M
Enterprise Value
37.58M
Revenue
20.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.60
Market Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 38.88M, a decrease of -65.83%. That is a compound annual growth rate of -12.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 38.88M | 183.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scandinavian ChemoTech AB | 92.91M |
| OncoZenge AB | 91.03M |
| Spago Nanomedical AB | 87.33M |
| Pila Pharma AB | 82.00M |
| Alzinova AB | 68.11M |
| Modus Therapeutics Holding AB | 59.84M |
| 2cureX AB | 54.22M |
| Guard Therapeutics International AB | 26.82M |